There are few illnesses as crafty as pancreatic cancer. It spreads like weeds and resists chemotherapy. Pancreatic cancer is often asymptomatic, has a low survival rate and is often misdiagnosed as diabetes. And, this violent killer is almost always inoperable…
Raleigh, NC, September 28th, 2018 – Advanced Chemotherapy Technologies, Inc. (www.advancedchemotech.com), a combination drug-device company focused on developing iontophoresis drug delivery devices, today announced receipt of a $1,111,364 grant from the National Cancer Institute of the National Institutes of Health…
Fueled by the passion of pioneering physicists, physicians and medtech innovators looking for a way to fight cancer and make an impact on patient survival and quality of life, cutting-edge oncology devices under development today include an implant designed to…
Pancreatic cancer is an elusive and deadly disease. It often has no initial symptoms, and there are no reliable tests for early detection. The mortality rate is 75 percent within a year of diagnosis, and the five-year survival rate is…
